TLX · Insider Trading
Telix Pharmaceuticals Limited American Depositary Shares
Every open-market purchase and sale reported by TLX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | Darren Charlton Smith | Group Chief Financial Officer | Buy | +2,071 | +$20.00K |
| 2026-05-06 | Christian Behrenbruch | MD & Group CEO | Buy | +67,935 | +$996.74K |
| 2026-04-01 | Darren Charlton Smith | Group Chief Financial Officer | M | +1,111 | — |
| 2009-12-16 | Richard Paul Brandt | — | C | +167,668 | — |
| 2009-12-16 | Victor S Liss | Director | C | +12,646 | — |
| 2009-12-16 | Howard S Modlin | Director | C | +11,373 | — |
| 2009-09-29 | Howard Brenner | Director | A | +500 deriv. | — |
| 2009-06-08 | Howard S Modlin | Director | A | +1,500 deriv. | — |
| 2009-06-08 | Jean Firstenberg | Director | A | +500 deriv. | — |
| 2008-06-06 | Howard Brenner | Director | A | +500 deriv. | — |
| 2008-06-06 | Victor S Liss | Director | A | +1,500 deriv. | — |
| 2008-06-06 | Howard S Modlin | Director | A | +1,000 deriv. | — |
| 2007-12-17 | Richard Paul Brandt | Director | A | +2,500 deriv. | — |
| 2007-09-14 | Richard Paul Brandt | Director | MIXED | +735 | +$2 |
| 2007-03-21 | Richard Paul Brandt | Director | A | +2,660 | +$20.00K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Christian Behrenbruch | MD & Group CEO | 20,742,935 | $232.53M |
| Darren Charlton Smith | Group Chief Financial Officer | 13,992 | $156.85K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TLX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.